ArticleCancer research communications2023

NCI 7977: A Phase I Dose-Escalation Study of Intermittent Oral ABT-888 (Veliparib) plus Intravenous Irinotecan Administered in Patients with Advanced Solid Tumors.

Michael Cecchini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.